Please provide your email address to receive an email when new articles are posted on . Ocrelizumab reduced the number and size of MS-related cortical lesions. Data synthesis featuring a mix of ...
Your Privacy is Important To Us. Buffalo.edu uses cookies to help build a better website experience for our visitors. Learn more in our Privacy Policy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback